About ALL4IBD program -
Monitoring patients from home has improved IBD out comes -
- Early and appropriate treatment of patients with IBD has been shown to reduce symptoms and complications including surgeries.
- However, most IBD patients do not have tools to track their symptoms and disease activity from home.
- Evidence for home-based monitoring has been steadily building in many chronic diseases including CHF, COPD, Diabetes .
Home Monitoring Improves Quality of Care for IBD patients (320 Patients) -
•After an average follow-up of 575±135 days,
•Quality metrics continued improving (84% intervention vs. 65% control)
•Significant change from baseline observed among HealthPROMISE users (+34 ppt vs. +15 ppt, p<0.01)
Home Monitoring can find symptoms not normally discussed during Clinic Visits such as anxiety and fatigue -
Alliance for IBD (All 4 IBD) Collaborative Built on Top Evidence Based App in IBD (Partner: Roche) -
All 4 IBD Quality Improvement (QI) overview -
1.Provide electronic patient reported outcomes (ePRO)‑based remote monitoring for the majority of patients in IBD centers to achieve Treat to Target goals and optimize patient experience
2.Reduce healthcare resource utilization and readmissions
3.Promote network collaboration and support for multi-site studies and trials
All4IBD- Enrollment form
All4IBD- Baseline Survey
All4IBD- Baseline Survey (Later) & Digital Readiness Survey
Link to download HealthPROMISE app following acceptance of terms and account creation-
Dashboard Onboarding -
HealthPROMISE App for Patients (Clinical Trial of 320 patients) -
Physician Dashboard to monitor patients from home -
Patient Onboarding -